Skip to main content

Table 4 Patient reported outcomes

From: Patient education booklet to support evidence-based low back pain care in primary care – a cluster randomized controlled trial

Outcome

Time

Intervention group n (total n = 145)

Control group n (total n = 161)

Intervention group

Meana (SE)

Control group

Meana (SE)

Mean differenceb (95% CI)

P value

Age-adjusted mean differenceb (95% CI)

P value

PROMIS T-scoreb

Baseline

139

152

44.7 (0.6)

43.8 (0.6)

0.9 (-0.7 to 2.6)

0.271

0.5 (-1.1 to 2.1)

0.526

 

Change 3 m

84

95

2.5 (0.7)

1.5 (0.7)

1.0 (-1.5 to 3.5)

0.365

0.93 (-1.0 to 2.9)

0.346

 

Change 12 m

67

91

2.2 (0.9)

2.3 (0.7)

-0.1 (-2.3 to 2.1)

0.923

0.09 (-2.3 to 2.2)

0.935

Low back pain intensity during last week (NRS, 0–10) b

Baseline

145

161

5.1 (0.3)

4.8 (0.3)

0.29 (-0.8 to 1.3)

0.521

0.38 (-0.7 to 1.5)

0.427

Change 3 m

91

105

-0.6 (0.5)

-0.4 (0.5)

-0.3 (-2.1 to 1.5)

0.732

-0.3 (-2.1 to 1.5)

0.695

Change 12 m

79

105

-1.8 (0.5)

-1.3 (0.5)

-0.47 (-2.1 to 1.2)

0.517

-0.5 (-2.2 to 1.1)

0.462

Leg pain intensity during last week LN [(NRS 0–10) + 0.5]e b

Baseline

145

161

0.9 (0.1)

0.9 (0.1)

0.1 (-0.4 to 0.5)

0.805

0.1 (-0.4 to 0.6)

0.708

Change 3 m

91

105

-0.2 (0.2)

0.01 (0.2)

-0.2 (-0.8 to 0.4)

0.407

-0.2 (-0.8 to 0.4)

0.395

Change 12 m

79

105

0.4 (0.2)

-0.2 (0.1)

-0.1 (-0.7 to 0.4)

0.506

-0.2 (-0.7 to 0.4)

0.491

ODI%b

Baseline

145

161

23.5 (1.3)

24.0 (1.2)

-0.5 (-4.0 to 3.1)

0.795

0.2 (-3.4 to 3.7)

0.925

 

Change 3 m

91

105

-5.1 (1.8)

-3.4 (1.7)

-1.7 (-7.6 to 4.1)

0.501

-1.7 (-7.6 to 4.1)

0.511

 

Change 12 m

79

104

-5.7 (2.4)

-4.1 (2.2)

-1.6 (-10.1 to 6.9)

0.645

-1.7 (-10.2 to 6.7)

0.619

EQ5D-3L indexdb

Baseline

145

161

0.659 (0.023)

0.664 (0.022)

-0.005 (-0.089 to 0.080)

0.890

 < 0.001 (< 0.001 to 0.084)

0.807

 

Change 12 m

79

107

0.048 (0.029)

0.053 (0.025)

0.005 (-0.081 to 0.071)

0.894

-0.007 (-0.083 to 0.070)

0.859

Self-rated health EQ5D-VAS (0–100)b

Baseline

144

159

68.2 (2.5)

67.1 (2.4)

1.1 (-7.3 to 9.4)

0.771

0.5 (-7.9 to 8.8)

0.899

 

Change 12 m

75

103

5.4 (2.4)

5.6 (2.1)

-0.1 (-6.5 to 6.2)

0–970

0.03 (-6.4 to 6.4)

0.992

    

% (n)

% (n)

OR (95% CI)

 

OR (95% CI)

 

LBP frequency (daily LBP yes/no)c

Baseline

147

161

43.4 (63)

50.9 (82)

0.79 (0.57 to 1.09)

0.143

0.80 (0.55 to 1.16);

0.244

 

3 months

  

38.7 (36)

42.6 (46)

0.94 (0.61 to 1.44)

0.768

0.94 (0.50 to 1.49)

0.792

 

12 months

83

107

28.9 (24)

32.7 (35)

0.85 (0.48 to 1.51)

0.586

0.84 (0.48 to 1.49)

0.560

  1. Presented as intervention group vs control group. aValues estimated from least square means with standard error. bLeast square mean difference estimated from linear mixed model with random effects for unit. Positive and negative mean differences indicate higher and lower values among intervention group, respectively. cDifference between intervention and control groups analyzed with logistic regression using generalized estimating equations with exchangeable working correlation matrix
  2. Change 3 m calculated from baseline to 3-month follow-up and change 12 m from baseline to 12-month follow-up
  3. dUK TTO
  4. NRS (Numeral rating scale), ODI (Oswestry Disability Index), PROMIS T-score (Patient-Reported Outcomes Measurement Information System, 20-item physical functioning short form T-score), EQ5D-3L index (EuroQol five dimensions, 3-level version)
  5. eLN (natural logarithmic) transformation for Leg pain intensity used because of positively skewed distribution